Revenue: The sum of all revenue fields included for a company's operating activities.
Akoya Biosciences, Inc. (AKYA) had Revenue of $81.67M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$81.67M |
$-55.37M |
|
$33.79M |
|
$47.88M |
|
$128.40M |
|
$-46.73M |
|
$-8.49M |
|
$-55.22M |
|
$-55.22M |
|
$-55.37M |
|
$-55.37M |
|
$-55.37M |
|
$-55.37M |
|
$-46.73M |
|
$-39.08M |
|
49.42M |
|
49.42M |
|
$-1.12 |
|
$-1.12 |
|
| Balance Sheet Financials | |
$76.73M |
|
$7.20M |
|
$48.27M |
|
$125.00M |
|
$29.44M |
|
$76.88M |
|
$87.97M |
|
$117.41M |
|
$7.59M |
|
$-25.23M |
|
$7.59M |
|
49.57M |
|
| Cash Flow Statement Financials | |
$-44.10M |
|
$-24.05M |
|
$-3.21M |
|
$83.82M |
|
$12.46M |
|
$-71.36M |
|
$9.31M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.61 |
|
-- |
|
-- |
|
0.91 |
|
10.20 |
|
58.62% |
|
-57.22% |
|
-57.22% |
|
-47.85% |
|
-67.61% |
|
-67.79% |
|
$-46.56M |
|
-- |
|
-- |
|
-- |
|
0.65 |
|
1.39 |
|
5.93 |
|
61.58 |
|
-728.97% |
|
219.48% |
|
-44.29% |
|
-65.54% |
|
$0.15 |
|
$-0.94 |
|
$-0.89 |
|